Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Heres

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Psychiatry|December 4, 2014
Long-acting injectable antipsychotics: an underutilized treatment optionStephan Heres
BMC Research Notes|July 29, 2017
Clozapine-induced, dilated cardiomyopathy: a case reportSarah Longhi, Stephan Heres
The Journal of Clinical Psychiatry|July 11, 2006
Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophreniaStefan Leucht, Stephan Heres
Psychiatric Services (Washington, D.C.)|March 11, 2015
Adapting shared decision making for individuals with severe mental illnessJohannes Hamann, Stephan Heres
Psychiatric Services (Washington, D.C.)|February 21, 2019
Why and How Family Caregivers Should Participate in Shared Decision Making in Mental HealthJohannes Hamann, Stephan Heres
Psychiatric Services (Washington, D.C.)|February 3, 2015
SDM will not be adopted if it is not adaptedJohannes Hamann, Stephan Heres
Evidence-Based Mental Health|October 27, 2007
Different antipsychotics produce similar, small improvements in psychosocial functioning at one year in people with schizophreniaStephan Heres, Werner Kissling, Stefan Leucht
Evidence-Based Mental Health|April 27, 2007
Review: little evidence to support dose escalation of selective serotonin reuptake inhibitors in non-respondersStephan Heres, Werner Kissling, Stefan Leucht
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 20, 2014
Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medicationJohannes Hamann, Werner Kissling, Stephan Heres
Evidence-Based Mental Health|April 27, 2007
Quetiapine is no less effective than risperidone for reducing symptoms of schizophreniaStephan Heres, Werner Kissling, Stefan Leucht
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Psychiatry|December 4, 2014
Long-acting injectable antipsychotics: an underutilized treatment optionStephan Heres
BMC Research Notes|July 29, 2017
Clozapine-induced, dilated cardiomyopathy: a case reportSarah Longhi, Stephan Heres
The Journal of Clinical Psychiatry|July 11, 2006
Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophreniaStefan Leucht, Stephan Heres
Psychiatric Services (Washington, D.C.)|March 11, 2015
Adapting shared decision making for individuals with severe mental illnessJohannes Hamann, Stephan Heres
Psychiatric Services (Washington, D.C.)|February 21, 2019
Why and How Family Caregivers Should Participate in Shared Decision Making in Mental HealthJohannes Hamann, Stephan Heres
Psychiatric Services (Washington, D.C.)|February 3, 2015
SDM will not be adopted if it is not adaptedJohannes Hamann, Stephan Heres
Evidence-Based Mental Health|October 27, 2007
Different antipsychotics produce similar, small improvements in psychosocial functioning at one year in people with schizophreniaStephan Heres, Werner Kissling, Stefan Leucht
Evidence-Based Mental Health|April 27, 2007
Review: little evidence to support dose escalation of selective serotonin reuptake inhibitors in non-respondersStephan Heres, Werner Kissling, Stefan Leucht
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 20, 2014
Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medicationJohannes Hamann, Werner Kissling, Stephan Heres
Evidence-Based Mental Health|April 27, 2007
Quetiapine is no less effective than risperidone for reducing symptoms of schizophreniaStephan Heres, Werner Kissling, Stefan Leucht
Pageof 9